Alector Inc. (ALEC)
NASDAQ: ALEC
· Real-Time Price · USD
1.49
0.11 (8.36%)
At close: Jun 24, 2025, 3:59 PM
1.49
0.34%
After-hours: Jun 24, 2025, 04:38 PM EDT
8.36% (1D)
Bid | 1.3 |
Market Cap | 148.49M |
Revenue (ttm) | 88.34M |
Net Income (ttm) | -123.44M |
EPS (ttm) | -1.26 |
PE Ratio (ttm) | -1.18 |
Forward PE | -0.93 |
Analyst | Buy |
Ask | 1.6 |
Volume | 355,724 |
Avg. Volume (20D) | 881,627 |
Open | 1.39 |
Previous Close | 1.38 |
Day's Range | 1.38 - 1.53 |
52-Week Range | 0.87 - 6.78 |
Beta | 0.72 |
About ALEC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALEC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALEC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Alector Inc. is scheduled to release its earnings on Aug 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-13.1%
Alector shares are trading lower after the company...
Unlock content with
Pro Subscription
7 months ago
-35.1%
Alector shares are trading lower after the company announced that the INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of AL002 in individuals with early Alzheimer's disease failed to meet its primary endpoint.